which found that treatment with Fasenra achieved a statistically significant improvement in the endoscopic total nasal polyp score and nasal blockage score compared to placebo, in patients with ...

The co-primary endpoints were change from baseline in total nasal polyp size (measured by endoscopic total Nasal Polyp Score) and change from baseline in bi-weekly mean nasal congestion (measured by ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

Both studies hit their co-primary endpoints of demonstrating that depemokimab improved the total endoscopic nasal polyp score at 52 weeks as well as the mean nasal obstruction score from weeks 49 ...

The study's co-primary endpoints were to see the change from baseline in total endoscopic nasal polyp score at 52 weeks and the change from baseline in mean nasal obstruction score from weeks 49 ...

Both trials met their co-primary endpoints of a change from baseline in total endoscopic nasal polyp score at 52 weeks and a change from baseline in mean nasal obstruction score from weeks 49 to 52.

A 7-year-old white female was admitted to the pediatric unit for recurrent bronchitis. She was referred to the otolaryngology clinic with complaints of chronic nasal stuffiness, usually clear with ...

Rheumatoid arthritis is an independent risk factor for CRSwNP recurrence after surgery, linked to higher tissue eosinophil counts, according to a recent study.

A study published in Frontiers in Medicine reveals that chronic rhinosinusitis with and without nasal polyps is closely correlated with asthma.A study was done to investigate the ...